Toric Intraocular Lens (IOL) Implantation for Management of Cataracts

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorEye & ENT Hospital of Fudan University

About this trial

This study included cataract patients who underwent toric intraocular lens (IOL) implantation, which aimed to evaluate the stability and clinical visual quality of toric IOLs.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Cataract

Disqualifiers

• small pupil

zonular dehiscence

preexisting corneal pathology

glaucoma

Trial population

Cataract patients who underwent uneventful lens phacoemulsification and toric IOL implantation.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

3,000 Participants
are grouped into 1 trial group
Group A: cataract patients implanted with toric IOLs

Trial outcomes

Primary outcomes

1

IOL rotation degree at one hour

After the pupil was dilated, the IOL axis was recorded using the same slit-lamp microscope. IOL rotation was defined as the difference between the target and final axis.

Time frame
one hour
2

IOL rotation degree at one day

After the pupil was dilated, the IOL axis was recorded using the same slit-lamp microscope. IOL rotation was defined as the difference between the target and final axis.

Time frame
one day
3

IOL rotation degree at three days

After the pupil was dilated, the IOL axis was recorded using the same slit-lamp microscope. IOL rotation was defined as the difference between the target and final axis.

Time frame
three days
4

IOL rotation degree at one week

After the pupil was dilated, the IOL axis was recorded using the same slit-lamp microscope. IOL rotation was defined as the difference between the target and final axis.

Time frame
one week

Secondary outcomes

1

visual quality at one week

visual acuity was evaluated by OPD-Scan III aberrometer.

Time frame
one week
2

visual quality at two weeks

visual acuity was evaluated by OPD-Scan III aberrometer.

Time frame
two weeks
3

visual quality at one month

visual acuity was evaluated by OPD-Scan III aberrometer.

Time frame
one month
4

visual quality at three months

visual acuity was evaluated by OPD-Scan III aberrometer.

Time frame
three months

Other outcomes

1

visual acuity at one day

uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) were recorded after surgery at one day

Time frame
one day
2

visual acuity at three days

uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) were recorded after surgery at three days

Time frame
three days
3

visual acuity at one week

uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) were recorded after surgery at one week

Time frame
one week
4

visual acuity at two weeks

uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) were recorded after surgery at two weeks

Time frame
two weeks

Sponsors and contacts

Click on the lead sponsor to view all of their trials.